New combo attack on tough head & neck cancers
NCT ID NCT07213934
Summary
This study aims to see if giving radiation therapy (either standard X-ray or proton therapy) along with an immunotherapy drug (pembrolizumab) before surgery is safe and more effective for people whose head and neck cancer has come back. The research will involve about 40 adults who are candidates for a second surgery. The main goals are to find the safest radiation dose and to see if this combined approach shrinks tumors better than immunotherapy alone before the operation.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEAD AND NECK CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Cincinnati Medical Center
Cincinnati, Ohio, 45219, United States
Conditions
Explore the condition pages connected to this study.